• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

L&H CEO steps down, cofounder leaves board

Article

John Duerden has called it quits as CEO of Lernout & Hauspie, although he remains on the board of directors. Philippe Bodson, formerly head of Belgian utility firm Tractebel, has been tapped to fill the vacancy as CEO. Meanwhile, company cofounder Jo

John Duerden has called it quits as CEO of Lernout & Hauspie, although he remains on the board of directors. Philippe Bodson, formerly head of Belgian utility firm Tractebel, has been tapped to fill the vacancy as CEO. Meanwhile, company cofounder Jo Lernout has stepped down from the board, although he will continue as chief technology officer.

In his first six months at the helm of the struggling voice recognition firm, Duerden ventured to Korea in search of $100 million in missing corporate funds and guided the company's first corporate steps toward bankruptcy protection (SCAN, 12/20/00). Now the odyssey is over.

The executive changes are coming just as L&H embarks on a massive restructuring effort as part of its bankruptcy protection plan, which has been granted in both the U.S. and Belgium. The company plans to cut 1200 jobs (about 20% of its workforce), shut down operations in South Korea, and withdraw from the retail market.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.